23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Strata Critical Medical, Inc. › 2025-2026

Strata Critical Medical, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Strata Critical Medical, Inc.’s Form 8-K, filed June 3, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 4Ballot items
  • 137Asset managers, any item
  • 625Fund votes
  • May 28, 2026Meeting date

Results at a glance

Meeting of May 28, 2026: 4 items on Strata Critical Medical, Inc.’s Form 8-K, filed June 3, 2026: 2 approved · 2 passed (calculated).

Dissent

Notable dissent: 1 director (15.1% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2024-2025 2025-2026

Activist investors: Third Point (13D, 5.8%, as of October 15, 2026) · Becker Drapkin (13F, 5.0%, as of September 30, 2026)

Explore Strata Critical Medical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Strata Critical Medical, Inc.

These tallies are Strata Critical Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Strata Critical Medical, Inc. — official shareholder meeting results, meeting held May 28, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: William A. Heyburn 46,050,902---- 505,42112,687,496 99%Passed (calculated)—
Elect Director: Andrew Lauck 39,525,159---- 7,031,16412,687,496 85%Passed (calculated)—
2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 58,946,83265,815231,172 ---- 99.9%Approved—
3. On an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote) 38,497,9628,022,68235,679 --12,687,496 83%Approved—

Source: Strata Critical Medical, Inc., Form 8-K, filed with the SEC on June 3, 2026 — read the filing on EDGAR.

How asset managers voted at the Strata Critical Medical, Inc. 2025-2026 meeting

137 asset managers disclosed a vote on at least one Strata Critical Medical, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Andrew Lauck

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD
FOR: 39,525,159WITHHELD: 7,031,164
Details: description as filed, official tally, votes by 46 asset managers

Description as filed by funds: Elect Class II Directors for terms expiring in 2029: Andrew Lauck

Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: Andrew Lauck”): 39,525,159 for, 7,031,164 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 14,813,867 for, 3,062,428 withheld, 31,589 abstained.

FORWITHHOLD
FOR: 14,813,867ABSTAIN: 31,589WITHHOLD: 3,062,428
Largest asset managers voting on “Elect Class II Directors for terms expiring in 2029: Andrew Lauck” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,008,6260 120For
Royce2,195,5810 00For
FIRST EAGLE FUNDS00 01,961,041Withhold
BlackRock1,284,1180 00For
Dimensional00 0470,318Withhold
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century00 0158,748Withhold
Russell Investments143,6830 00For
Principal Exchange-Traded Funds00 0125,339Withhold
TIAA00 0106,509Withhold
JPMorgan97,7210 00For
Equitable32,0300 049,530Mixed
Lincoln Financial00 049,927Withhold
Fidelity37,2530 00For
AIG/SunAmerica00 033,188Withhold
Global X32,4690 00For
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust5,3110 021,189Mixed
Jackson National00 25,3490Abstain
Virtus00 022,136Withhold
AQR00 015,781Withhold
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

Elect Director: William A. Heyburn

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 46,050,902WITHHELD: 505,421
Details: description as filed, official tally, votes by 46 asset managers

Description as filed by funds: Elect Class II Directors for terms expiring in 2029: William A. Heyburn

Strata Critical Medical, Inc.’s own tally for this item (“Elect Director: William A. Heyburn”): 46,050,902 for, 505,421 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 17,857,945 for, 49,938 withheld, 1 abstained.

FOR
FOR: 17,857,945ABSTAIN: 1WITHHOLD: 49,938
Largest asset managers voting on “Elect Class II Directors for terms expiring in 2029: William A. Heyburn” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,006,2700 12,367For
Royce2,195,5810 00For
FIRST EAGLE FUNDS1,961,0410 00For
BlackRock1,284,1180 00For
Dimensional470,3180 00For
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century158,7480 00For
Russell Investments143,6830 00For
Principal Exchange-Traded Funds125,3390 00For
TIAA106,5090 00For
JPMorgan97,7210 00For
Equitable81,5600 00For
Lincoln Financial49,9270 00For
Fidelity37,2530 00For
AIG/SunAmerica33,1880 00For
Global X00 032,469Withhold
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust26,5000 00For
Jackson National25,3490 00For
Virtus22,1360 00For
AQR15,7810 00For
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

On an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote)

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

83% Approved · of votes cast

FOR 83%AGAINST
FOR: 38,497,962AGAINST: 8,022,682

Prior year: 66.8% for (May 6, 2025 meeting) ▲ 16.0 pts

Details: description as filed, official tally, votes by 137 asset managers

Description as filed by funds: Advisory Vote on the Compensation of our Named Executive Officers.

Strata Critical Medical, Inc.’s own tally for this item (“3. On an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote)”): 38,497,962 for, 8,022,682 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers (the "Say-on-Pay" vote).”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 46 asset managers voting on “Advisory Vote on the Compensation of our Named Executive Officers.” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard2,522,129486,509 00Mixed
Royce2,195,5810 00For
FIRST EAGLE FUNDS01,961,041 00Against
BlackRock1,284,1180 00For
Dimensional0470,318 00Against
BNY Mellon312,9900 00For
Charles Schwab0201,557 00Against
American Century0158,748 00Against
Russell Investments0143,683 00Against
Principal Exchange-Traded Funds0125,339 00Against
TIAA106,5090 00For
JPMorgan097,721 00Against
Equitable32,03049,530 00Mixed
RBB FUND, INC.62,6610 00For
Lincoln Financial44,6005,327 00Mixed
Fidelity37,2530 00For
AIG/SunAmerica033,188 00Against
Global X032,469 00Against
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust026,500 00Against
Jackson National025,349 00Against
Virtus022,136 00Against
AQR015,781 00Against

Fund voting reports, all 46 managers: 14,050,178 for, 3,920,367 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 109 asset managers voting on “Advisory Vote on the Compensation of our Named Executive Officers.” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Third Point5,000,0000 00For
Northern Right Capital Management, L.P.3,069,3250 00For
First Eagle Investment Management, LLC02,266,243 00Against
Amova Asset Management Co., Ltd.01,654,361 00Against
Uniplan Investment Counsel, Inc.1,007,8970 00For
ARK Investment Management LLC712,5240 00For
BlackRock624,10721,107 00For
Newton Investment Management North America, LLC611,6440 00For
Royce565,3190 00For
State Street524,8671,491 00For
Vanguard284,37830,312 00Mixed
Russell Investments0266,288 00Against
Northern Trust0255,716 00Against
Charles Schwab0201,808 00Against
American Century0158,748 00Against
MELLON INVESTMENTS Corp144,3250 00For
PRINCIPAL GLOBAL INVESTORS0128,411 00Against
STATE OF WISCONSIN INVESTMENT BOARD0118,359 00Against
Nuveen117,4540 00For
Goldman Sachs116,8930 00For
Renaissance0111,480 00Against
Dimensional089,209 00Against
AllianceBernstein073,940 00Against
STIFEL NICOLAUS & CO INC \MO\072,768 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC069,875 00Against

Institutional-manager reports, all 109 managers: 12,923,190 for, 6,011,383 against. Showing the 25 largest; every one is in the interactive database (link above).

The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%
FOR: 58,946,832AGAINST: 65,815

Prior year: 99.9% for (May 6, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 46 asset managers

Description as filed by funds: RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 (DELOITTE & TOUCHE LLP).

Strata Critical Medical, Inc.’s own tally for this item (“2. The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 58,946,832 for, 65,815 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 17,907,884 for.

FOR
FOR: 17,907,884
Largest asset managers voting on “RATIFY APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026 (DELOITTE & TOUCHE LLP).” at Strata Critical Medical, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust7,369,7900 00For
Vanguard3,008,6380 00For
Royce2,195,5810 00For
FIRST EAGLE FUNDS1,961,0410 00For
BlackRock1,284,1180 00For
Dimensional470,3180 00For
BNY Mellon312,9900 00For
Charles Schwab201,5570 00For
American Century158,7480 00For
Russell Investments143,6830 00For
Principal Exchange-Traded Funds125,3390 00For
TIAA106,5090 00For
JPMorgan97,7210 00For
Equitable81,5600 00For
Lincoln Financial49,9270 00For
Fidelity37,2530 00For
AIG/SunAmerica33,1880 00For
Global X32,4690 00For
Pacific Life30,2330 00For
Bridge Builder Trust29,6910 00For
Venerable Variable Insurance Trust26,5000 00For
Jackson National25,3490 00For
Virtus22,1360 00For
AQR15,7810 00For
Goldman Sachs14,0290 00For

Showing the 25 largest of 46 asset managers. All 46 are in the interactive database (link above).

Largest Strata Critical Medical, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 86,526,570 shares outstanding at the time of that meeting.

Fund voting reports: top Strata Critical Medical, Inc. shareholders by shares voted on “Advisory Vote on the Compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1ARK ETF Trust 8.52%
2Vanguard 3.48%
3Royce 2.54%
4FIRST EAGLE FUNDS 2.27%
5BlackRock 1.48%
6Dimensional 0.54%
7BNY Mellon 0.36%
8Charles Schwab 0.23%
9American Century 0.18%
10Russell Investments 0.17%
Institutional-manager reports: top Strata Critical Medical, Inc. shareholders by shares voted on “Advisory Vote on the Compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1Third Point 5.78%
2Northern Right Capital Management, L.P. 3.55%
3First Eagle Investment Management, LLC 2.62%
4Amova Asset Management Co., Ltd. 1.91%
5Uniplan Investment Counsel, Inc. 1.16%
6ARK Investment Management LLC 0.82%
7BlackRock 0.75%
8Newton Investment Management North America, LLC 0.71%
9Royce 0.65%
10State Street 0.61%

Reported Strata Critical Medical, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Strata Critical Medical, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Steele ExpCo Holdings, LLC7,923,000 9.16%Schedule 13G, filed August 20, 2026
BlackRock4,568,268 5.28%Form 13F, quarter ended March 31, 2026
Vanguard Group3,633,537 4.20%Form 13F, quarter ended March 31, 2026
ARK Investment Management LLC2,730,855 3.16%Schedule 13G, filed July 8, 2026
Dimensional Fund Advisors1,617,104 1.87%Form 13F, quarter ended March 31, 2026
State Street1,346,075 1.56%Form 13F, quarter ended March 31, 2026
BNY Mellon1,079,025 1.25%Form 13F, quarter ended March 31, 2026
Morgan Stanley766,449 0.89%Form 13F, quarter ended March 31, 2026
Northern Trust643,635 0.74%Form 13F, quarter ended March 31, 2026
Renaissance Technologies474,886 0.55%Form 13F, quarter ended March 31, 2026

Percentages above are of 86,526,570 shares outstanding, as reported by Strata Critical Medical, Inc. on its Form 10-Q dated April 27, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Strata Critical Medical, Inc.'s shareholder meeting held May 28, 2026, in the 2025-2026 proxy season, 137 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 625 separate fund positions. On the most widely held item on that ballot — Advisory Vote on the Compensation of our Named Executive Officers. — Strata Critical Medical, Inc.'s filing reports the proposal as approved, with 83% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Strata Critical Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Strata Critical Medical, Inc.’s 10-Q dated April 27, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Strata Critical Medical, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Strata Critical Medical (SRTA) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/strata-critical-medical-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.